Remedy Plan Therapeutics has commenced dosing in a randomised Phase I trial of hyperbolic nicotinamide ...
Footage shows a demonstration of the single-sheet hyperboloid model. A math enthusiast used a straight road to illustrate how ...
Remedy Plan Therapeutics, a privately-held clinical-stage pharmaceutical company transforming the field of NAMPT inhibition, announced today the initiation of an adult healthy volunteer Phase 1 ...